Health
New mRNA-Based Flu Vaccine Approaching Market
Moderna is set to release the first mRNA-based flu shot for the upcoming season. The vaccine aims to provide better protection for older individuals.
Coverage timeline — 1 article
NPR
The first mRNA-based flu shot to be approved by the Food and Drug Administration will be ready for the upcoming flu season. Moderna, the vaccine's maker
2026-08-06 17:06 UTC